Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
1.720
+0.040 (2.38%)
Mar 3, 2026, 4:00 PM EST - Market closed
Health Catalyst Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Health Catalyst stock have an average target of 4.06, with a low estimate of 2.75 and a high estimate of 5.00. The average target predicts an increase of 136.05% from the current stock price of 1.72.
Analyst Consensus: Hold
* Price targets were last updated on Jan 9, 2026.
Analyst Ratings
The average analyst rating for Health Catalyst stock from 10 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 8 | 8 | 8 | 8 | 8 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $3.25 → $2.75 | Hold | Maintains | $3.25 → $2.75 | +59.88% | Jan 9, 2026 |
| Citigroup | Citigroup | Hold Maintains $3.5 → $3.25 | Hold | Maintains | $3.5 → $3.25 | +88.95% | Nov 11, 2025 |
| Stifel | Stifel | Hold Maintains $4.5 → $3.75 | Hold | Maintains | $4.5 → $3.75 | +118.02% | Nov 11, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +190.70% | Nov 11, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +74.42% | Oct 8, 2025 |
Financial Forecast
Revenue This Year
316.69M
from 306.58M
Increased by 3.30%
Revenue Next Year
307.66M
from 316.69M
Decreased by -2.85%
EPS This Year
0.20
from -1.15
EPS Next Year
0.36
from 0.20
Increased by 79.60%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 327.1M | 321.4M | ||
| Avg | 316.7M | 307.7M | ||
| Low | 303.8M | 292.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.7% | 1.5% | ||
| Avg | 3.3% | -2.9% | ||
| Low | -0.9% | -7.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.26 | 0.65 | ||
| Avg | 0.20 | 0.36 | ||
| Low | 0.17 | 0.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 220.5% | ||
| Avg | - | 79.6% | ||
| Low | - | -18.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.